NCT02873169 - Determination of Risk Factors of Ventricular Arrhythmias (VAs) After Implantation of Continuous Flow Left Ventricular Assist Device With Continuous Flow Left Ventricular Assist Device (CF-LVAD) | Biotech Hunter

Enrollment

681

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Severe Cardiac Insufficiency

Interventions

OTHER

Implantable cardioverter-defibrillator

Collection of clinical, biological, hemodynamic and rhythmic data

Trial Locations (20)

13385

AP-HM - Hôpital de la Timone, Marseille

21079

CHU de Dijon, Dijon

33600

CHU de Bordeaux, Bordeaux

34295

CHRU de Montpellier, Montpellier

35033

CHU de Rennes, Rennes

37170

CHRU de Tours, Tours

38700

CHU de Grenoble, Grenoble

44000

CHU de Nantes, Nantes

54500

CHRU de Nancy, Nancy

59037

CHRU de Lille, Lille

63003

CHU Clermont Ferrand, Clermont-Ferrand

67091

Hôpitaux Universitaires de Strasbourg, Strasbourg

69677

Hospices Civils de Lyon - Hôpital Louis Pradel, Bron

75015

Hôpital Européen Georges Pompidou, Paris

76000

CHU de Rouen, Rouen

92350

Centre chirurgical Marie-Lannelongue, Le Plessis-Robinson

94010

Hôpital Henri Mondor, Créteil

Unknown

CHU de Caen, Caen

APHP - Hôpital Bichat, Paris

CHU de Toulouse, Toulouse

All Listed Sponsors

lead

Rennes University Hospital

OTHER